Table 1

Select characteristics of the US Air Force study population

CharacteristicTGCT cases (N=530)Controls (N=530)
N (%)N (%)
Age at serum sample collection (year)
<20141 (26.6)134 (25.3)
20–24194 (36.6)220 (41.5)
25–2995 (17.9)76 (14.3)
30–3464 (12.1)66 (12.4)
35–3928 (5.3)27 (5.1)
40+8 (1.5)7 (1.3)
Age at TGCT diagnosis (year)
<2010 (1.9)
20–24111 (20.9)
25–29159 (30)
30–34113 (21.3)
35–3989 (16.8)
40+48 (9.1)
Mean±SD29.8±6.6
Race/ethnicity at case diagnosis
Non-Hispanic white422 (79.6)422 (79.6)
Non-Hispanic black13 (2.4)13 (2.4)
Hispanic57 (10.8)57 (10.8)
Asian/Pacific Islander6 (1.1)6 (1.1)
Native American/Alaska Native5 (0.9)5 (0.9)
Other9 (1.7)9 (1.7)
Unknown18 (3.4)18 (3.4)
Education at case diagnosis
≤High school261 (49.3)268 (50.6)
Some college120 (22.6)138 (26)
Bachelor's80 (15.1)57 (10.8)
Advanced degree68 (12.8)66 (12.4)
Unknown1 (0.2)1 (0.2)
Grade at case diagnosis
Enlisted (E01–E10)410 (77.4)435 (82.1)
Officer (O1–O10)120 (22.6)95 (17.9)
Height (m) at military accession
Mean±SD1.65±0.241.61±0.21
% Missing190 (35.8)181 (34.2)
Weight (kg) at military accession
Mean±SD69.9±2.5969.5±2.48
% Missing190 (35.8)181 (34.2)
Number of deployments before case dx year
0386 (72.8)354 (67.4)
181 (15.3)92 (17.4)
235 (6.6)50 (9.4)
≥328 (5.3)32 (5.8)
Years of service at serum sample collection
Mean±SD2.4±3.32.4±3.3
Years of service at case dx
Mean±SD8.2±5.38.2±5.2
Time between serum collection and case dx (years)
Mean±SD5.8±4.45.8±4.4
Calendar year of military accession
Median (range)1998 (1986–2017)1998 (1986–2017)
Calendar year of serum sample draw
Median (range)1999 (1988–2017)1999 (1989–2017)
Calendar year at case dx
Median (range)2007 (1990–2018)2007 (1990–2018)
Tumour morphology
Seminoma293 (55.3)
Non-seminoma237 (44.7)
  • Controls individually matched to cases on: race/ethnicity, military accession year (±1 year), date of birth (±1 year) and serum sample collection date (±1 year).

  • *Defined as a deployment record with a length of ≥31 days outside of the USA.

  • dx, diagnosis; TGCT, testicular germ cell tumour.